What are the side effects of Cosentyx (secukinumab)?

Commonly reported side effects of Cosentyx (secukinumab) include: candida, fatigue, gum inflammation, mouth inflammation, oral irritation, oral thrush, psoriasis flare, sore throat, suicidal ideation. This treatment also carries an FDA black box warning.

How long does Cosentyx (secukinumab) take to work?

Cosentyx (secukinumab) typically shows results in 12–16 weeks, though individual responses vary.

Is Cosentyx (secukinumab) safe for long-term use?

Cosentyx (secukinumab) is considered safe for long-term use. Always consult your physician.

psoriasis Treatment Guide

Does Cosentyx (secukinumab) work for psoriasis?

Q: Does Cosentyx (secukinumab) work for psoriasis?

Research gives Cosentyx (secukinumab) a score of 81/100 for psoriasis (Strong), based on 45 studies. Real user reports score it 76/100.

Cosentyx (secukinumab) has a research efficacy score of 81/100 for psoriasis — rated Strong across 45 studies. Real users on social media rate it 76/100. It typically takes 12–16 weeks to show results.

Research

81 / 100

45 studies

Social

76 / 100

46 posts

Safety

72 / 100

See if Cosentyx works for you — not just on average

Track daily, run your own experiment, get real data. Free.

Cosentyx (secukinumab) — treatment for psoriasis

How does Cosentyx (secukinumab) help psoriasis?

IL-17A inhibition

Category: biologic immunosuppressant

Efficacy: Research vs. Real Users

Research Evidence

81 / 100

Strong

45 studies · 324212 participants

Score derived from PubMed research published in the past year.

Real User Reports

76 / 100

Strong

46 posts

Self-reported results can be biased. Use as context, not proof.

How It Works

Administration Injection, Monthly
Time to work 12–16 weeks
Adult dose target Adults with moderate-to-severe plaque psoriasis, including palmoplantar and nail involvement, who have failed or are intolerant to conventional systemic therapies, with particularly low immunogenicity risk compared to other biologics.
Child dose target Children with moderate-to-severe plaque psoriasis who have inadequate response to conventional therapies, with low-dose secukinumab ranking first for PASI 90 response among pediatric biologics.

Safety Profile

⚠ FDA Black Box Warning

This treatment carries an FDA black box warning — the most serious type of safety alert. Consult your doctor before use.

/ 100

Safety Score: Moderate

Higher scores indicate a more favorable safety profile.

Known Side Effects

candida
fatigue
gum inflammation
mouth inflammation
oral irritation
oral thrush
psoriasis flare
sore throat
suicidal ideation

Cautions

✓ Generally considered safe during pregnancy

✓ Considered safe for long-term use

Who Should Consider Cosentyx (secukinumab)?

Severity Moderate, severe
Minimum age 6 years old
Effective areas palms, soles, nails
Category Non-steroid Prescription Medication

Lemma Health

Download the app — free.

Track your own Cosentyx experiment and see whether it's actually helping — backed by your own data.

Frequently Asked Questions

Does Cosentyx (secukinumab) work for psoriasis?: Research gives Cosentyx a score of 81/100 for psoriasis (Strong), based on 45 studies. Real-user reports score it 76/100.
What are the side effects of Cosentyx (secukinumab)?: Commonly reported side effects include: candida, fatigue, gum inflammation, mouth inflammation, oral irritation, oral thrush, psoriasis flare, sore throat, suicidal ideation. This treatment also carries an FDA black box warning.
How long does Cosentyx (secukinumab) take to work?: Cosentyx typically shows results in 12–16 weeks, though individual responses vary. Tracking your symptoms with a structured experiment can help you know sooner.
Is Cosentyx (secukinumab) safe for long-term use?: Cosentyx is considered safe for long-term use. Always confirm with your physician.
How do you use Cosentyx (secukinumab)?: Cosentyx is administered injection, Monthly, at a target dose of Adults with moderate-to-severe plaque psoriasis, including palmoplantar and nail involvement, who have failed or are intolerant to conventional systemic therapies, with particularly low immunogenicity risk compared to other biologics..
Is Cosentyx (secukinumab) safe during pregnancy or breastfeeding?: Cosentyx is generally considered safe during pregnancy. Always confirm with your healthcare provider.

This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any treatment. Scores are derived from publicly available research and social media data and should not be used as a substitute for professional medical guidance.